U B Hofmann

Summary

Country: Germany

Publications

  1. ncbi Matrix metalloproteinases in human melanoma
    U B Hofmann
    Department of Pathology, University Hospital, Nijmegen, The Netherlands
    J Invest Dermatol 115:337-44. 2000
  2. ncbi Coexpression of integrin alpha(v)beta3 and matrix metalloproteinase-2 (MMP-2) coincides with MMP-2 activation: correlation with melanoma progression
    U B Hofmann
    Department of Pathology and Surgery, University Hospital, Nijmegen, The Netherlands
    J Invest Dermatol 115:625-32. 2000
  3. ncbi [Role of matrix-degrading enzymes in melanoma progression]
    U B Hofmann
    Universitätsklinik und Poliklinik für Hautkrankheiten, Julius Maximilians Universitat, Wurzburg, Germany
    Hautarzt 53:587-95. 2002
  4. ncbi Calcitriol vs. dithranol in combination with narrow-band ultraviolet B (311 nm) in psoriasis
    U B Hofmann
    Department of Dermatology, University of Wurzburg, Josef Schneider Str 2, D 97080 Wurzburg, Germany
    Br J Dermatol 148:779-83. 2003
  5. ncbi Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression
    U B Hofmann
    Department of Pathology, University Hospital, Nijmegen, The Netherlands
    J Pathol 191:245-56. 2000
  6. ncbi Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo
    U B Hofmann
    Department of Pathology, University Hospital, Nijmegen, The Netherlands
    Int J Cancer 87:12-9. 2000
  7. ncbi Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression
    U B Hofmann
    Department of Pathology, University Hospital, Nijmegen, The Netherlands
    Br J Cancer 81:774-82. 1999
  8. ncbi [Nevus of Ota and choroid melanoma]
    P Terheyden
    , ,
    Hautarzt 52:803-6. 2001

Detail Information

Publications8

  1. ncbi Matrix metalloproteinases in human melanoma
    U B Hofmann
    Department of Pathology, University Hospital, Nijmegen, The Netherlands
    J Invest Dermatol 115:337-44. 2000
    ....
  2. ncbi Coexpression of integrin alpha(v)beta3 and matrix metalloproteinase-2 (MMP-2) coincides with MMP-2 activation: correlation with melanoma progression
    U B Hofmann
    Department of Pathology and Surgery, University Hospital, Nijmegen, The Netherlands
    J Invest Dermatol 115:625-32. 2000
    ..These findings strongly suggest that co-ordinated expression of both factors may be required for melanoma cell invasion and metastasis formation...
  3. ncbi [Role of matrix-degrading enzymes in melanoma progression]
    U B Hofmann
    Universitätsklinik und Poliklinik für Hautkrankheiten, Julius Maximilians Universitat, Wurzburg, Germany
    Hautarzt 53:587-95. 2002
    ..In this review we discuss these functional aspects of melanoma progression...
  4. ncbi Calcitriol vs. dithranol in combination with narrow-band ultraviolet B (311 nm) in psoriasis
    U B Hofmann
    Department of Dermatology, University of Wurzburg, Josef Schneider Str 2, D 97080 Wurzburg, Germany
    Br J Dermatol 148:779-83. 2003
    ..In order to reduce cumulative UV doses and to enhance clearance of psoriasis plaques, combination therapies with topical agents such as dithranol and calcipotriol have been established...
  5. ncbi Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression
    U B Hofmann
    Department of Pathology, University Hospital, Nijmegen, The Netherlands
    J Pathol 191:245-56. 2000
    ....
  6. ncbi Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo
    U B Hofmann
    Department of Pathology, University Hospital, Nijmegen, The Netherlands
    Int J Cancer 87:12-9. 2000
    ..Furthermore, MT1-MMP and alpha(v)beta(3) are co-localized on the cell membrane of tumor cells. These findings suggest that activated MT1-MMP co-localized with alpha(v)beta(3) may be involved in activation of alpha(v)beta(3)-bound MMP-2...
  7. ncbi Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression
    U B Hofmann
    Department of Pathology, University Hospital, Nijmegen, The Netherlands
    Br J Cancer 81:774-82. 1999
    ....
  8. ncbi [Nevus of Ota and choroid melanoma]
    P Terheyden
    , ,
    Hautarzt 52:803-6. 2001
    ..Although the nevus of Ota is rare in Caucasians, associated melanoma is more common than in Asians or black people. The dermatologist should be aware of this problem and aim at an interdisciplinary management of these patients...